Is human rights forensics a viable profession?
The aim of this study was (1) to determine the longitudinal progression of FVCpp in patients with MDC1A, analyzing both ambulatory and non-ambulatory cohorts as well as those on or not on ventilation support (VS) and (2) to determine if FCVpp is a viable outcome marker for progression of disease.
Therefore, incomplete vitrectomy is a viable option, to delay the progression of glaucoma.
Indeed, it has been suggested that targeting tumor associated fibroblasts [ 30] and the stromal EGFR may be a viable approach for preventing tumor progression and impeding the angiogenic switch.
Together, these findings suggest decreasing Rac1 or RhoA expression, or alternatively, interfering with their ability to achieve or maintain the active GTP-bound state [ 50], is a viable strategy to reduce CRC progression and metastasis.
These findings suggest there is a viable time window to prevent progression from GDM to T2D and highlights those women who are at the greatest risk and should therefore be prioritised for preventative intervention.
Additional studies are needed to determine whether the frequency of these monocyte subsets correlates with cognitive performance and whether CD16+ or CD16+/CD163+ monocyte frequency can serve as a viable biomarker for HIV disease progression and neurocognitive impairment.
This study highlights those women with GDM who are at the greatest risk of progressing from GDM to T2D and should therefore be prioritised for preventative intervention and suggests there is a viable time window to prevent progression from GDM to T2D in the majority of women.
Together, results from these novel hormonal agents show that men with 'castrate-resistant' PCa still maintain a degree of hormonal sensitivity and that further endocrine therapy after progression may be a viable option.
Because PC-3 cells were responsive to BMS-777607 but not the anti-HGF antibody, the findings also indicate that under circumstances where c-Met is constitutively hyperactive in the absence of functional HGF, targeting the c-Met receptor remains a viable therapeutic option to impede cancer progression.
Targeting intracellular signaling cascades downstream of TGFβ rather than TGFβ itself may also be a viable approach for blocking fibrogenesis and cancer progression.
